Femasys Inc (FEMY) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Femasys Inc   (NASDAQ: FEMY)
 

Femasys Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Femasys Inc 's inventory turnover ratio sequentially decreased to 0.15 in the second quarter 2026, unsurprisingly, as the Femasys Inc markets continue to deteriorate, and FEMY's faces growing challenges to bring down its inventories. Femasys Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 2433 days, from 2281 days, in the Mar 31 2026 quarter.

Within Healthcare sector 374 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1953, from total ranking in the first quarter 2026 at 2111.

FEMY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Femasys Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FEMY Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 18.32 % 58.08 % 88.43 % 198.5 % 297.75 %
Y / Y Cost of Sales Growth -9.95 % 35.25 % 57.53 % 53.97 % 116.3 %
Inventory Turnover Ratio (TTM) 0.15 0.16 0.17 0.17 0.19
FEMY's Total Ranking # 1953 # 2111 # 2035 # 2041 # 2046
Average inventory processing period 2421 2283 2157 2147 1950
Seq. Inventory Growth 1.41 % 6.36 % -0.76 % 10.53 % 35.49 %
Seq. Cost of Sales Growth -10.2 % -47.67 % 3.15 % 85.77 % 34.88 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 165
Healthcare Sector # 375
Overall Market # 1953

Inventory Turnover Ratio Statistics
High Average Low
3.01 0.86 0.15
(Mar 31 2022)   (Jun 30 2026)



FEMY Company Profile >> Back to FEMY Efficiency Comparisons >> Compare FEMY Inventory Turnover Ratio to its Competitors

Financial Statements
Femasys Inc 's Inventories $ 6 Millions Visit FEMY's Balance sheet
Femasys Inc 's Cost of Revenues TTM $ 1 Millions Visit FEMY's Income Statement
What are FEMY's Sales? Visit FEMY's Sales by Segment

Other Inventory Turnover Ratios
Femasys Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
FEMY's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for FEMY's Competitors
Inventory Turnover Ratio for FEMY's Suppliers
Inventory Turnover Ratio for FEMY's Customers

You may also want to know
FEMY's Sales Growth Rates FEMY's Pe Price to earnings ratio FEMY's Receivables Turnover Ratio FEMY's Stock Quote
FEMY's Net Income Growth Rates FEMY's Ps Price to Sales ratio FEMY's Sales per Employee FEMY's Asset Turnover Ratio
FEMY's Net Margin FEMY's Pb Price to Book ratio FEMY's Financial Strength Ratios FEMY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
EBR Systems, Inc.  0.39 $ 5.514  Millions$ 14  Millions
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions
Citius Oncology Inc  0.04 $ 0.821  Millions$ 21  Millions
Vireo Growth Inc.  0.03 $ 2.485  Millions$ 85  Millions

Date modified: 2026-08-16T08:12:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.